Micro-elimination of hepatitis C in patients with chronic kidney disease and diabetes in Taiwan
Journal of the Formosan Medical Association · 2025
DOI: 10.1016/j.jfma.2025.10.044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the Formosan Medical Association, 2025. Verfasst von Kuo-Chin Chang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Med…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Hepatitis C, Diabetes Mellitus, Disease Eradication. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
National governments across the globe are devising strategies to achieve the World Health Organization (WHO) goal of hepatitis C virus (HCV) elimination by 2030. The Taiwan government has also set an ambitious target of reaching 80 % treatment coverage for HCV by 2025. The HCV micro-elimination approach, which focuses on treating smaller, targeted high-risk subpopulations-such as people who inject drugs (PWID), individuals co-infected with HIV/HCV, prisoners, and patients with end-stage renal disease (ESRD)-has been proposed as an effective strategy for achieving global HCV elimination. Patients with CKD and DM exhibit a higher prevalence of HCV infection compared to the general population. Treating HCV in these individuals can improve glycemic control, slow CKD progression, and reduce both hepatic and extrahepatic complications and mortality. A novel finding from the Changhua Integrated Program to Stop HCV Infection (CHIPS-C) in Changhua County, revealed that patients with DM and CKD comprise at least 45 % of all HCV-infected individuals. Screening for HCV in patients with DM and CKD can identify more cases easily when integrated into Taiwan's well-established shared care system. Micro-elimination targeting HCV in patients with CKD and DM have been designated as a national policy priority for HCV elimination in Taiwan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
- Institute of Epidemiology and Preventive Medicine, College of Public Health & Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taiwan; Changhua County Public Health Bureau, Chang…
- Changhua County Public Health Bureau, Changhua, Taiwan.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
- Changhua Christian Hospital, Changhua, Taiwan.
- Changhua Hospital, Ministry of Health and Welfare, Changhua, Taiwan.
Zitieren
APA
Chang, K. C., Yeh, Y. P., Chen, S. S., Hsieh, M. L., San Lim, L., Chen, J. F., Tsao, Y. Y., Chen, Y. C., Wang, W. C., Liu, H. C., Su, W. W., Yang, C. C., Wu, C. K., Chien, R. N., Hu, T. H., Lee, C. T., & Hsiu-Hsi Chen, T. (2025). Micro-elimination of hepatitis C in patients with chronic kidney disease and diabetes in Taiwan. Journal of the Formosan Medical Association. https://doi.org/10.1016/j.jfma.2025.10.044
Vancouver
Chang KC, Yeh YP, Chen SS, Hsieh ML, San Lim L, Chen JF, et al. Micro-elimination of hepatitis C in patients with chronic kidney disease and diabetes in Taiwan. Journal of the Formosan Medical Association. 2025. doi:10.1016/j.jfma.2025.10.044
BibTeX
@article{Chang2025,
author = {Chang, Kuo-Chin and Yeh, Yen-Po and Chen, Shiou-Shiang and Hsieh, Ming-Ling and San Lim, Lay and Chen, Jung-Fu and Tsao, Yo-Yu and Chen, Ya-Chi and Wang, Wei-Chuen and Liu, Hui-Chun and Su, Wei-Wen and Yang, Chih-Chao and Wu, Cheng-Kun and Chien, Rong-Nan and Hu, Tsung-Hui and Lee, Chien-Te and Hsiu-Hsi Chen, Tony},
title = {Micro-elimination of hepatitis C in patients with chronic kidney disease and diabetes in Taiwan},
journal = {Journal of the Formosan Medical Association},
year = {2025},
doi = {10.1016/j.jfma.2025.10.044}
}
EUVIMED